PLSEPulse Biosciences, Inc.

$1B

Q3 2017 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$0

Gross Profit

-$166,000

Operating Income

-$8M

Net Income

-$7M

EPS (Diluted)

$-0.52

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$54M

Total Liabilities

$4M

Stockholders' Equity

$50M

Cash & Equivalents

$32M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$166,000	-$166,000	+0.0%
Operating Income	-$8M	-$3M	-168.9%
Net Income	-$7M	-$3M	-170.5%

PLSE Q3 2017 Earnings — Pulse Biosciences, Inc. Revenue & Financial Results | Market Cap Arena